FDA approves Treximet for migraine treatment
April 16th 2008 20:01
I wanted to update you on the FDA approval of the new migraine drug Treximet (sumatriptan and naproxen sodium tablets).I had posted prior on this possible approval.GlaxoSmithKline and POZEN partnered in this,have been trying for approval since 2005.Double-blind trials w/2900 patients,resulting in more patients migraine releif with Treximet @ 2-4 hours than sumatriptan 85mg, naproxen sodium 500mg or placebo alone. Along with this,Treximet maintained pain releif longer, from 2 -24hrs.Multiple mechanisms of migraine are targeted by Treximet combining a triptan and an NSAID in one tablet.
Treximet is due to be available the middle of May 2008.
More information at gsk.com
source:mymigraines.com
Treximet is due to be available the middle of May 2008.
source:mymigraines.com
| 74 |
| Vote |
Add To: 
subscribe to this blog
